For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241106:nRSF2185La&default-theme=true
RNS Number : 2185L Alumasc Group PLC (The) 06 November 2024
The Alumasc Group plc
(the "Company")
6 November 2024
PDMR/PCA dealing
The Company announces that it received notification on 5 November 2024 that
Mrs. Luan Leaf, a person closely associated to Mr Michael Leaf, an Executive
Director, exercised 10,000 options over ordinary shares of 12.5p each
("Ordinary Shares") at a price of 225.66p each, held under the 2021 Alumasc
Employee Share Option Scheme. Following the exercise Mrs. Leaf sold 8,370 of
the resulting Ordinary Shares to cover tax, national insurance and the option
exercise price.
Following the above Michael Leaf's total holding (including shares held by his
Person Closely Associated) was:
Total holding of Shares % of issued share capital
Michael Leaf 144,227 0.399
Settlement of the award was made from existing Ordinary Shares held by the
Alumasc Employee Benefit Trust.
The below notification, made in accordance with the requirements of the EU
Market Abuse Regulation, gives further detail of the transactions.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name Luan Leaf (Person closely associated with Michael Leaf)
2. Reason for the notification
a. Position/status Persons closely associated to Michael Leaf - Executive Director
b. Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name The Alumasc Group plc
b. LEI 2138002MV11VKZFJ4359
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the
Financial instrument, type Options over Ordinary Shares of 12.5p each
of instrument Ordinary Shares of 12.5p each
Identification code
Ordinary Shares: GB0000280353
b. Nature of the transaction Vesting of shares award under The Alumasc Group plc 2014 Executive Share
Option Plan (2021 Scheme)
c. Price(s) and volume(s)
Price(s) Volume(s)
Exercise
225.66p 10,000
Sale
310p 8,370
d. Aggregated information
· Aggregated volume
· Price
As above
e. Date of the transaction 2024-11-5
f. Place of the transaction Exercise and sale: Off-market
d.
Aggregated information
· Aggregated volume
· Price
As above
e.
Date of the transaction
2024-11-5
f.
Place of the transaction
Exercise and sale: Off-market
Enquiries:
The Alumasc Group plc +44 (0)1536 383844
Paul Hooper (Chief Executive)
Simon Dray (Group Finance Director)
Helen Ashton (Group Company Secretary)
Peel Hunt (Broker) +44 (0)207 418 8831
Mike Bell
Ed Allsopp
Cavendish Capital Markets Ltd (Nominated Adviser) +44 (0)207 220 0500
Julian Blunt
Edward Whiley
Camarco (Financial PR) alumasc@camarco.co.uk (mailto:alumasc@camarco.co.uk)
Ginny Pulbrook +44 (0)203 757 4992
Tilly Butcher
Notes to Editors:
Alumasc is a UK-based supplier of premium sustainable building products,
systems and solutions. Almost 80% of Group sales are driven by building
regulations and specifications (architects and structural engineers) because
of the performance characteristics offered.
The Group has three business segments with strong positions and brands in
their individual markets. The three segments are: Water Management; Building
Envelope; and Housebuilding Products.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFSAFDMELSEDF